Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

The article provides summaries of several medical studies. One study examines the use of apixaban for stroke prevention in patients with subclinical atrial fibrillation, finding that it reduces the risk of stroke but increases the risk of major bleeding. Another study investigates the use of semaglutide in overweight and obese patients without diabetes, showing that it reduces the risk of cardiovascular events. A third study explores the use of dexamethasone in HIV-positive adults with tuberculous meningitis, finding that it does not reduce mortality. Additionally, a study in Nigeria examines the prevalence of foot-at-risk among outpatients with diabetes, highlighting the need for foot screening and education. Finally, a study examines the long-term risk of cervical cancer in women with cervical intraepithelial neoplasia grade 2, showing that active surveillance is associated with an increased risk. [Extracted from the article]